GLP-1 injectable therapies, including Mounjaro, Wegovy, and Ozempic, have rapidly gained popularity in India for diabetes and weight loss since their 2025 launch. These drugs mimic gut hormones to regulate blood sugar and suppress appetite. While effective, experts emphasize the necessity of a thorough diagnostic work-up before prescription, including tests like hemoglobin A1c and fasting plasma glucose, as these medications are not suitable for everyone.